For a firmer you, ask for Sculptra®

Sculptra® activates the skins ability to produce collagen1. It renews skin thickness and firmness, correcting shallow to deep wrinkles and folds2.  Sculptra® works gradually to build the foundations of a youthful, firmer you, day after day3.

Why renew?
Why use Sculptra, a collagen injectable from Galderma aesthetics

Why Sculptra®?

Sculptra® activates the skin’s ability to produce collagen, restoring the skin’s structure and firmness4. Collagen is a fibrous protein in the deeper layers of your skin and it plays a crucial role in keeping your skin looking young and healthy. As you age, your body’s collagen production decreases which in time leads to loose and saggy skin and the formation of facial wrinkles and folds5.
 
Sculptra®, the original collagen stimulator, helps renew your skin gradually with long-lasting results6. Sculptra® can provide more radiant-looking skin over time, giving you natural-looking results.

Treatment areas

Treatment areas

The Sculptra® collagen skin renewal treatment rejuvenates sagging skin by increasing volume and firmness7. Sculptra® helps gradually diminish smile lines (nasolabial folds), laugh lines (or marionette lines) and wrinkles to help give you firm and radiant-looking skin. Results may last for up to two years8. Sculptra® can help you achieve the look you desire.  

According to a clinical study9, 80% of users were still satisfied with their Sculptra® collagen stimulators treatment up to 25 months after their last injection.

Treatments with The Galderma aesthetics range - Sculptra, a collagen injectable
CHEEKS, MID FACE, LOWER FACE
Your treatment
light
Sculptra, a collagen injectable - treatments for you

Your Sculptra® treatment

Sculptra® is injected in the deep layers of your skin to stimulate its own collagen production10. You will gradually notice visible improvements of skin firmness and fullness, with results that can last up to two years11. On average, three Sculptra® treatment sessions are needed over a few months. Your doctor will work with you to determine the number of treatments needed to help achieve the look you want.

 

Sculptra® works subtly, improving facial areas gradually to help give you youthful and natural-looking results. 

How it works
light
Sculptra - the science behind

How it works

The active ingredient in Sculptra® is poly-L-Lactic acid, PLLA. PLLA is a biodegradable substance that has been used for decades in dissolvable stitches for wound management. When PLLA is injected into the deeper layers of your skin, it helps stimulate your skin’s own collagen production12. Sculptra® can help rejuvenate skin volume that has been lost due to aging13.

80%

of patients rated Sculptra® as good to excellent after up to 25 months14

100%

of patients would recommend Sculptra® to a friend15

Proven aesthetic results since

200616

Before & After

Hillary_Durham_BEFORE
Sanne_Friis_BEFORE
Hillary_Durham_BEFORE
Sanne_Friis_BEFORE
Before Hillary_Durham_BEFORE
After Hillary_Durham_AFTER
Caption
  • Multiple treatments and/or products may have been used
  • Individual results may vary
  • Consult your doctor to determine what treatment is best for you
Before Sanne_Friis_BEFORE
After Sanne_Friis_AFTER
Caption
  • Multiple treatments and/or products may have been used
  • Individual results may vary
  • Consult your doctor to determine what treatment is best for you

Frequently asked questions

As with any injection, some pain at the treatment site is possible. Our healthcare practitioner may use optional addition of a local anesthetic lidocaine. Consult your doctor about what to expect prior to treatment.

Sculptra® is designed to give you noticeable results that emerge gradually with increased collagen production. Sculptra® can give you noticable results that emerge subtly. Because results happen gradually, you may notice subtle reductions in the appearance of facial wrinkles and folds over time. Your healthcare professional will determine the best treatment plan for you. Because results happen gradually, you will see subtle, yet noticeable, results in the reduction of facial wrinkles and folds by comparing images before treatment and a couple months following treatment.*

*Safety and effectiveness of Sculptra® have not been evaluated in areas other than nasolabial wrinkles and folds.

To help ensure safe use and obtain optimal results, it is important that you comply with the aftercare instructions provided by your doctor. In the days following your treatment, for swift healing and optimum results:

Cold pack: A cold pack or ice pack will help reduce any common swelling and/or bruising. Within the first 24 hours of treatment, apply a cloth-wrapped cold pack to the treated area for a few minutes at a time. Never apply ice directly to the skin.

Facial massage: Massage the treated area for five minutes five times a day for five days after treatment to promote a natural looking correction, as recommended by your healthcare practitioner.

Avoid sunlight and UV esposure: After treatment, excessive sunlight and UV lamp exposure should be avoided until any initial swelling and redness have disappeared. Your healthcare practitioner will provide guidelines on sunscreen protection and how to avoid excessive sunlight.

If there are no complications, you may apply makeup several hours after treatment. Be sure to consult your healthcare practitioner after treatment for more. 

Sculptra® was CE approved for aesthetic use in the European market in 1999 and approved in Canada in 2006. Sculptra® is made of a synthetic material called poly-L-lactic acid that is absorbed naturally by the body and has been used for years in dissolvable stitches. Sculptra® does not contain any human or animal components.

Common side effects reported include pain at the treatment area, redness, bruising, tenderness, itching and lumps, bleeding or swelling. Small bumps under the skin can sometimes be noticeable when pressing on the treated area. Larger lumps, with or without inflammation, have also been reported. This is only a partial list of possible side effects. For a complete list of all side effects, please click here. If you are experiencing side effects, talk to your healthcare practitioner.

Sculptra® is indicated for use in people as a single regimen for the correction of skin depressions by stimulating collagen production. You should not receive treatment if you have an active skin infection or skin inflammation near the planned injection site.

Sculptra® should not be used by people that are allergic to any ingredient of the product or have a history and/or susceptibility of keloid formation or hypertrophic scarring. Safety has not been established in patients who are pregnant, lactating, breastfeeding or under 21 years of age and is not recommended for use. 

Skin insights

Galderma aesthetics and Restylane - Aesthetic treatments with dermal fillers have been used for many years.

How to find an aesthetic clinic that you can trust

Are you looking for a clinic?

find your nearest clinic

Our portfolio of products

Galderma has developed a diverse portfolio of products that work together.

The Galderma aesthetics range, Restylane Lyft and Deyfne

Refine

Refine your facial features by lifting and shaping contours, filling lines and wrinkles or creating natural-looking volume.

The Galderma aesthetics range, Restylane Skinboosters

Refresh

Refresh your skin from within with a boost of hyaluronic acid, for a refreshed and vibrant long-lasting look.

References

  1. Stein P et al. J Dermatol Sci 2015;78(1):26–33.; Goldberg D et al. Dermatol Surg 2013;39(6):915–22.; Moyle GJ et al. HIV Med 2004;5(2):82–7.
  2. Nelson L and Stewart KJ. J Plast Reconstr Aesthet Surg 2012;65(4):439–47.; Moyle GJ et al. HIV Med 2004;5(2):82–7.; Mest DR and Humble G. Dermatol Surg 2006;32(11): 1336–45.; Valantin MA et al. AIDS 2003;17(17):2471–7.; Narins RS et al. J Am Acad Dermatol 2010;62(3):448–62.; Brandt FS et al. Aesthet Surg J 2011;31(5):521–8.
  3. Stein P et al. J Dermatol Sci 2015;78(1):26–33.9.; Goldberg D et al. Dermatol Surg 2013;39(6):915–22.; Vleggaar D et al. J Drugs Dermatol 2014;13(4 suppl):s29–31.; Moyle GJ et al. HIV Med 2004;5(2):82–7.; Bohnert K et al. Plast Reconstr Surg 2019;127(4):1684–92
  4. Stein P et al. J Dermatol Sci 2015;78(1):26–33.9.; Goldberg D et al. Dermatol Surg 2013;39(6):915–22.; Vleggaar D et al. J Drugs Dermatol 2014;13(4 suppl):s29–31.; Moyle GJ et al. HIV Med 2004;5(2):82–7.
  5. Fisher GJ et al. Arch Dermatol 2008;144(5):666–72.; Werschler WP et al. J Clin Aesthet Dermatol 2015;8(10 Suppl):S2–S7.
  6. Stein P et al. J Dermatol Sci 2015;78(1):26–33.9.; Goldberg D et al. Dermatol Surg 2013;39(6):915–22.; Vleggaar D et al. J Drugs Dermatol 2014;13(4 suppl):s29–31.; Moyle GJ et al. HIV Med 2004;5(2):82–7.
  7. Stein P et al. J Dermatol Sci 2015;78(1):26–33.9.; Goldberg D et al. Dermatol Surg 2013;39(6):915–22.; Vleggaar D et al. J Drugs Dermatol 2014;13(4 suppl):s29–31.; Moyle GJ et al. HIV Med 2004;5(2):82–7.
  8. Narins RS et al. J Am Acad Dermatol 2010;62(3):448–62.; Brandt FS et al. Aesthet Surg J 2011;31(5):521–8. 
  9. Brown SA et al. Plast Reconstr Surg 2011;127(4):1684–92.
  10. Stein P et al. J Dermatol Sci 2015;78(1):26–33.; Goldberg D et al. Dermatol Surg 2013;39(6):915–22.; Moyle GJ et al. HIV Med 2004;5(2):82–7.
  11. Brown SA et al. Plast Reconstr Surg 2011;127(4):1684–92.
  12. Stein P et al. J Dermatol Sci 2015;78(1):26–33.; Goldberg D et al. Dermatol Surg 2013;39(6):915–22.; Moyle GJ et al. HIV Med 2004;5(2):82–7.
  13. Stein P et al. J Dermatol Sci 2015;78(1):26–33.; Goldberg D et al. Dermatol Surg 2013;39(6):915–22.; Moyle GJ et al. HIV Med 2004;5(2):82–7.; Nelson L and Stewart KJ. J Plast Reconstr Aesthet Surg 2012;65(4):439–47.; Mest DR and Humble G. Dermatol Surg 2006;32(11): 1336–45.; Valantin MA et al. AIDS 2003;17(17):2471–7.; Narins RS et al. J Am Acad Dermatol 2010;62(3):448–62.; Brandt FS et al. Aesthet Surg J 2011;31(5):521–8.; Chen HH et al. JAMA Facial Plast Surg 2015;17(1):39–43.
  14. Brown SA et al. Plast Reconstr Surg 2011;127(4):1684–92.
  15. Mest DR and Humble G. Dermatol Surg 2006;32(11):1336–45.
  16. Sculptra was developed and CE approved for aesthetic use in the European market in 1999.